Tag: exocrine pancreatic insufficiency market overview

  • Global Exocrine Pancreatic Insufficiency Market Report 2024: Size, Drivers, And Top Segments

    Global Exocrine Pancreatic Insufficiency Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Exocrine Pancreatic Insufficiency Market from 2024 to 2033?

    The exocrine pancreatic insufficiency market has grown robustly, expected to increase from $2.41 billion in 2023 to $2.59 billion in 2024, with a CAGR of 7.6%. Contributing factors include greater awareness and diagnosis of the condition, rising prevalence of digestive disorders, an aging population, and increased gastrointestinal surgeries.

    The exocrine pancreatic insufficiency market is expected to grow significantly, reaching $3.34 billion by 2028 at a CAGR of 6.5%. This growth is attributed to increasing awareness and screening efforts, the growing geriatric population, rising chronic disease prevalence, improved patient access to healthcare, and research advancements in digestive health. Major trends include telehealth and digital health solutions, collaborative research, a focus on pediatric EPI, regulatory advancements, market expansion in emerging economies, and improvements in healthcare infrastructure.

    Claim Your Free Sample of the Global Exocrine Pancreatic Insufficiency Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp

    What Key Factors Are Fueling the Growth of the Exocrine Pancreatic Insufficiency Market?

    The growing prevalence of chronic diseases is anticipated to drive the exocrine pancreatic insufficiency market. Chronic diseases, which persist for extended periods, often lead to complications like exocrine pancreatic insufficiency, necessitating effective management and therapeutic interventions. In January 2023, the National Library of Medicine projected that the number of people aged 50 or older with chronic illnesses would rise by 99.5% by 2050, reaching 142.66 million in the US. Therefore, the rise in chronic diseases will accelerate the growth of the exocrine pancreatic insufficiency market.

    What Are the Major Segments of the Exocrine Pancreatic Insufficiency Market?

    1) By Treatment: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Other Treatments

    2) By Diagnosis: Imaging Tests, Computed Tomography (CT) Scan, Abdominal Ultrasound, Secretin Pancreatic Function Test, Fecal Fat Test, Fecal Elastase Test (FE-1), Other Types

    3) By Symptoms: Abdominal Pain, Constipation, Diarrhea, Fatty Stools, Weight Loss, Other Symptoms

    4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

    5) By End Users: Hospitals, Specialty Clinics, Homecare

    What New Trends Are Transforming the Exocrine Pancreatic Insufficiency Market?

    Companies in the exocrine pancreatic insufficiency market are focusing on patient advocacy groups to promote patient-centric product development. These groups provide support and information to patients, empowering them to understand their condition and treatment options. In November 2021, Aimmune Therapeutics partnered with Mission: Cure to create an online community for patients with exocrine pancreatic insufficiency and chronic pancreatitis, offering support and shared experiences to help manage these conditions.

    Order Now for Fast Delivery of Your Exocrine Pancreatic Insufficiency Market Report!

    https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report

    Which Regions Are Driving Growth in the Exocrine Pancreatic Insufficiency Market?

    North America was the largest region in the exocrine pancreatic insufficiency market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Exocrine Pancreatic Insufficiency Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the exocrine pancreatic insufficiency market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Exocrine Pancreatic Insufficiency Market Include

    1. Exocrine Pancreatic Insufficiency Market Executive Summary

    2. Exocrine Pancreatic Insufficiency Market Segments

    3. Exocrine Pancreatic Insufficiency Market Size And Template Market Growth Rate

    4. Key Exocrine Pancreatic Insufficiency Market Trends

    5. Major Exocrine Pancreatic Insufficiency Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Exocrine Pancreatic Insufficiency Market

    26. Top Exocrine Pancreatic Insufficiency Companies

    27. Exocrine Pancreatic Insufficiency Market Opportunities And Strategies

    28. Exocrine Pancreatic Insufficiency Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report

    Mineral And Bone Disorder Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

    Home Infusion Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Insights On The Exocrine Pancreatic Insufficiency Market 2024 – Size, Driver, And Major Players

    Key Insights On The Exocrine Pancreatic Insufficiency Market 2024 – Size, Driver, And Major Players

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Exocrine Pancreatic Insufficiency Global Market Report 2024, the exocrine pancreatic insufficiency market is expected to show significant growth in the forecast period.

    The exocrine pancreatic insufficiency (EPI) market has witnessed robust growth in recent years, with significant projections for the future. Here’s a breakdown of the market’s evolution and what’s driving its expansion:

    1. Historic Growth Factors:
      • Increased awareness and diagnosis
      • Growing prevalence of digestive disorders
      • Aging population and pancreatic function decline
      • Rise in gastrointestinal surgeries
    2. Forecasted Growth Drivers:
      • Continued increase in awareness and screening
      • Expanding geriatric population
      • Rising incidence of chronic diseases
      • Improvements in patient access to healthcare
      • Research and development in digestive health

    View More On The Exocrine Pancreatic Insufficiency Market Report 2024 – https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report

    1. Emerging Trends:
      • Telehealth and digital health solutions
      • Collaborative research initiatives
      • Focus on pediatric EPI
      • Regulatory advances and fast-track designations
      • Market expansion in emerging economies
      • Advancements in healthcare infrastructure

    Impact of Chronic Diseases on Market Expansion

    The prevalence of chronic diseases plays a pivotal role in propelling the growth of the EPI market. Here’s why:

    • Prolonged Medical Conditions: Chronic diseases persist over an extended period, increasing the likelihood of secondary complications like EPI.
    • Rising Demographics: The aging population contributes significantly to chronic disease prevalence.
    • Secondary Complications: EPI arises as a secondary condition, emphasizing the need for better management of chronic illnesses.

    Key Players and Patient-Centric Approaches

    Major companies in the EPI market are adopting patient-centric strategies to enhance product development and support.

    • Patient Advocacy Groups: These groups empower individuals affected by EPI, providing crucial support and information.
    • Example: Aimmune Therapeutics partnered with Mission: Cure to establish an online patient community, facilitating information exchange and support.

    Strategic Acquisitions and Market Segmentation

    Strategic acquisitions and market segmentation are shaping the competitive landscape of the EPI market.

    • Acquisition of First Wave Bio Inc.: AzurRx Biopharma’s acquisition expanded its gastrointestinal therapies portfolio, strengthening its position in the market.
    • Market Segmentation: The EPI market is segmented based on treatment, diagnosis, symptoms, distribution channels, and end-users, offering tailored solutions.

    Regional Dynamics

    Regional trends play a significant role in the growth trajectory of the EPI market.

    • North America: Emerged as the largest region in 2023.
    • Asia-Pacific: Expected to witness the fastest growth in the forecast period, highlighting evolving healthcare landscapes.

    Conclusion

    The exocrine pancreatic insufficiency market is poised for substantial growth driven by various factors such as increasing awareness, strategic initiatives, and evolving healthcare needs. With a focus on innovation and patient-centric approaches, the market is set to witness transformative advancements in the coming years.

    Request A Sample Of The Global Exocrine Pancreatic Insufficiency Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13107&type=smp